Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMO | NYSE
Chart Builder DCF Calculator
$685.13
-$11.87 (-1.70%)
Nov 2, 2026, 1:17 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Net Income
6.72B 6.34B 6B 6.96B 7.73B 6.38B
Depreciation & Amortization
2.78B 3.11B 3.41B 3.38B 2.59B 2.33B
Stock-Based Compensation
310M 301M 278M 307M 230M 196M
Other Working Capital
-1.69B -348M -844M -442M -768M 1.36B
Other Non-Cash Items
412M 463M 564M 550M 957M 340M
Deferred Income Tax
-639M -1.21B -1.3B -995M -406M -552M
Change in Working Capital
-1.77B -334M -537M -1.05B -1.56B -395M
Operating Cash Flow
7.82B 8.67B 8.41B 9.15B 9.54B 8.29B
Capital Expenditures
-1.53B -1.4B -1.48B -2.24B -2.52B -1.47B
Cash Acquisitions
-4.04B -3.13B -3.66B -39M -19.4B -38M
Purchase of Investments
-383M -3.4B n/a -15M -8M n/a
Sales Maturities Of Investments
1.57B 1.77B 70M 15M 8M n/a
Other Investing Acitivies
333M 317M -73M 123M -14M 2M
Investing Cash Flow
-4.05B -5.84B -5.14B -2.16B -21.93B -1.51B
Debt Repayment
5.35B -2.4B -155M 654M 8.91B 2.75B
Common Stock Repurchased
-3B -4B -3B -3B -2B -1.5B
Dividend Paid
-636M -583M -523M -455M -395M -337M
Other Financial Acitivies
90M 194M 56M -9M 65M 46M
Financial Cash Flow
1.8B -6.79B -3.62B -2.81B 6.58B 959M
Net Cash Flow
5.84B -4.06B -440M 4.05B -5.85B 7.91B
Free Cash Flow
6.29B 7.27B 6.93B 6.91B 7.02B 6.82B
Adj. Free Cash Flow
5.98B 6.97B 6.65B 6.6B 6.79B 6.62B
Maintenance CapEx
-1.12B -1.39B -1.48B -1.03B -1.13B -277.93M
Growth CapEx
-402.18M -5.14M n/a -1.21B -1.39B -1.2B
Owner Earnings
6.7B 7.27B 6.93B 8.12B 8.41B 8.01B

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.